Detalles de la búsqueda
1.
IgG1 responses following SARS-CoV-2 infection are polyclonal and highly personalized, whereby each donor and each clone displays a distinct pattern of cross-reactivity against SARS-CoV-2 variants
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-481778
2.
Bispecific antibodies combine breadth, potency, and avidity of parental antibodies to neutralize sarbecoviruses
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-516125
3.
Mapping the antigenic diversification of SARS-CoV-2
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21268582
4.
Cross-reactive antibodies after SARS-CoV-2 infection and vaccination
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21256092
5.
Broad SARS-CoV-2 Neutralization by Monoclonal and Bispecific Antibodies Derived from a Gamma-infected Individual
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-512216
6.
Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects Macaques from infection
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-453755
7.
Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21257441
8.
A public antibody class recognizes a novel S2 epitope exposed on open conformations of SARS-CoV-2 spike
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-470767
9.
Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-365726
Resultados
1 -
9
de 9
1
Próxima >
>>